Anticoagulant drugs: what is new? (Journal article)
Kei, A./ Florentin, M./ Elisaf, M. S./ Liberopoulos, E.
Heparins and vitamin K antagonists have been the cornerstones of anticoagulation treatment for several decades. Despite their effectiveness, these agents have limitations which can include food and drug interactions and the need for monitoring. It follows that there is a need for new anticoagulants. There are numerous promising agents at various stages of evaluation. Those in the most advanced stages of development are the oral factor Xa and the thrombin inhibitors, which are the focus of this review.
|Institution and School/Department of submitter:||Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής|
|Keywords:||Administration, Oral,Animals,Anticoagulants/administration & dosage/adverse,effects/pharmacokinetics/*therapeutic use,Antithrombins/therapeutic use,Blood Coagulation/*drug effects,Factor Xa/antagonists & inhibitors,Hemorrhage/chemically induced,Humans,Risk Assessment|
|Appears in Collections:||Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)|
Files in This Item:
There are no files associated with this item.
Please use this identifier to cite or link to this item:This item is a favorite for 0 people.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.